FDA NDC Directory · JSON-LD · Markdown

LYNKUET

NDC 50419-475 · HUMAN PRESCRIPTION DRUG · CAPSULE

Generic nameelinzanetant
Labeler / ManufacturerBayer HealthCare Pharmaceuticals Inc.
Marketing categoryNew Drug Application (innovator) · App NDA219469
Dosage form / routeCAPSULE · ORAL
Active ingredientsELINZANETANT (60 mg/1)
Marketing started20251024
Package count3

External sources

Source: openFDA. Public-domain (CC0).